Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest safe dose of sorafenib that
can be given in combination with radiation therapy to people with lung cancer. The ability of
both the study drug and radiation to control the disease will also be studied.